Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Symptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factors.

Higginson IJ, Gao W, Saleem TZ, Chaudhuri KR, Burman R, McCrone P, Leigh PN.

PLoS One. 2012;7(11):e46327. doi: 10.1371/journal.pone.0046327.

2.

Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease.

Pinkhardt EH, Jürgens R, Becker W, Valdarno F, Ludolph AC, Kassubek J.

J Neurol. 2008 Dec;255(12):1916-25. doi: 10.1007/s00415-009-0027-y.

PMID:
19224319
3.

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.

Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ.

Brain. 2002 Apr;125(Pt 4):861-70.

4.

Health-related quality of life in multiple system atrophy and progressive supranuclear palsy.

Winter Y, Spottke AE, Stamelou M, Cabanel N, Eggert K, Höglinger GU, Sixel-Doering F, Herting B, Klockgether T, Reichmann H, Oertel WH, Dodel R.

Neurodegener Dis. 2011;8(6):438-46. doi: 10.1159/000325829.

PMID:
21576919
5.

PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes.

Raffel DM, Koeppe RA, Little R, Wang CN, Liu S, Junck L, Heumann M, Gilman S.

J Nucl Med. 2006 Nov;47(11):1769-77.

6.

Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.

Juh R, Kim J, Moon D, Choe B, Suh T.

Eur J Radiol. 2004 Sep;51(3):223-33.

PMID:
15294329
7.

Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.

Federico F, Simone IL, Lucivero V, Mezzapesa DM, de Mari M, Lamberti P, Petruzzellis M, Ferrari E.

Ital J Neurol Sci. 1999 Aug;20(4):223-9.

PMID:
10551908
8.

The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life.

Antonini A, Barone P, Marconi R, Morgante L, Zappulla S, Pontieri FE, Ramat S, Ceravolo MG, Meco G, Cicarelli G, Pederzoli M, Manfredi M, Ceravolo R, Mucchiut M, Volpe G, Abbruzzese G, Bottacchi E, Bartolomei L, Ciacci G, Cannas A, Randisi MG, Petrone A, Baratti M, Toni V, Cossu G, Del Dotto P, Bentivoglio AR, Abrignani M, Scala R, Pennisi F, Quatrale R, Gaglio RM, Nicoletti A, Perini M, Avarello T, Pisani A, Scaglioni A, Martinelli PE, Iemolo F, Ferigo L, Simone P, Soliveri P, Troianiello B, Consoli D, Mauro A, Lopiano L, Nastasi G, Colosimo C.

J Neurol. 2012 Dec;259(12):2621-31. doi: 10.1007/s00415-012-6557-8.

PMID:
22711157
9.

Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging.

Eckert T, Sailer M, Kaufmann J, Schrader C, Peschel T, Bodammer N, Heinze HJ, Schoenfeld MA.

Neuroimage. 2004 Jan;21(1):229-35.

PMID:
14741660
10.

Psychometric Properties of a Generic, Patient-Centred Palliative Care Outcome Measure of Symptom Burden for People with Progressive Long Term Neurological Conditions.

Gao W, Crosby V, Wilcock A, Burman R, Silber E, Hepgul N, Chaudhuri KR, Higginson IJ; OPTCARE Neuro trial..

PLoS One. 2016 Oct 25;11(10):e0165379. doi: 10.1371/journal.pone.0165379.

11.

Progression of parkinsonism in multiple system atrophy.

Seppi K, Yekhlef F, Diem A, Luginger Wolf E, Mueller J, Tison F, Quinn NP, Poewe W, Wenning GK.

J Neurol. 2005 Jan;252(1):91-6.

PMID:
15654560
12.

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN; NNIPPS Study Group..

Brain. 2009 Jan;132(Pt 1):156-71. doi: 10.1093/brain/awn291.

13.

Symptom prevalence, severity and palliative care needs assessment using the Palliative Outcome Scale: a cross-sectional study of patients with Parkinson's disease and related neurological conditions.

Saleem TZ, Higginson IJ, Chaudhuri KR, Martin A, Burman R, Leigh PN.

Palliat Med. 2013 Sep;27(8):722-31. doi: 10.1177/0269216312465783.

PMID:
23208011
14.

Anal sphincter EMG in the diagnosis of parkinsonian syndromes.

Winge K, Jennum P, Lokkegaard A, Werdelin L.

Acta Neurol Scand. 2010 Mar;121(3):198-203. doi: 10.1111/j.1600-0404.2009.01169.x.

PMID:
19785640
15.

Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.

Ozsancak C, Auzou P, Dujardin K, Quinn N, Destée A.

J Neurol. 2004 Nov;251(11):1317-23.

PMID:
15592726
16.

Health-related quality of life in multiple system atrophy.

Schrag A, Geser F, Stampfer-Kountchev M, Seppi K, Sawires M, Köllensperger M, Scherfler C, Quinn N, Pellecchia MT, Barone P, Del Sorbo F, Albanese A, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Nilsson CF, Widner H, Lindvall O, Giladi N, Gurevich T, Daniels C, Deuschl G, Coelho M, Sampaio C, Abele M, Klockgether T, Schimke N, Eggert KM, Oertel W, Djaldetti R, Colosimo C, Meco G, Poewe W, Wenning GK; European MSA-Study Group..

Mov Disord. 2006 Jun;21(6):809-15.

PMID:
16502399
17.

Health related quality of life in Parkinson's disease: a prospective longitudinal study.

Karlsen KH, Tandberg E, Arsland D, Larsen JP.

J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):584-9.

18.

The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism.

Ha AD, Brown CH, York MK, Jankovic J.

Parkinsonism Relat Disord. 2011 Sep;17(8):625-8. doi: 10.1016/j.parkreldis.2011.05.020.

PMID:
21689962
19.
20.

Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.

Linder J, Stenlund H, Forsgren L.

Mov Disord. 2010 Feb 15;25(3):341-8. doi: 10.1002/mds.22987.

PMID:
20108376
Items per page

Supplemental Content

Support Center